Among the multiple cardiovascular therapies taken before admission, only ACE-I/ARBs showed an association with mortality (OR = 0.47 (95% CI: 0.23–0.95; p = .037) after adjusting for advanced cancer, bedridden status, WBC, age, glycaemia, HF, heart rate, albumin. The gene discussed is ALB; the disease is hydrops fetalis.